Bio-Rad Hits 52-Week High; Stratagene Leads Index | GenomeWeb
Shares in Bio-Rad Laboratories hit a 52-week high this week, closing Monday at $80.42, up 2.4 percent for the trading period ended Monday — a day earlier than normal due to the Thanksgiving holiday in the US this week. Stratagene led all gainers in the BCW Index with a 7.5 percent jump for the week. Qiagen led decliners for the week with a drop of 4.9 percent.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.